Here’s some good news to report to our teenage audience and their dermatologists. Candela Corporation, maker of the Smoothbeam–“the first FDA approved laser for acne treatment”–is reporting positive long term results from a recent study:
The most commonly diagnosed skin disorder in the U.S. and the number one reason for a patient’s visit to a dermatologist — acne — can now have long-term clearance with Smoothbeam® laser treatment, according to a recent study published in The Journal of the American Academy of Dermatology…
As acne affects nearly 80 percent of the population worldwide, the need for effective and lasting treatments continues to grow. That’s one reason why researchers treated twenty patients of varying skin tones, with three Smoothbeam laser treatments at four-week intervals. The study found a 75 percent reduction in the number of acne lesions in all subjects after the final treatment, with significant improvement seen after the first laser treatment. Additionally, acne scarring was improved by 26-50 percent in all patients studied post treatment.
“While the Smoothbeam laser is known to effectively treat acne, this study is the first that demonstrates the long-term clearing of acne with laser treatment in patients of all skin types,” said Dr. Ming H. Jih, lead investigator.